Anesthetic Management for Concurrent GLP-1 and Opioid Use

Authors

• Zainab Raza, Oakland University William Beaumont School of Medicine Medical Student
• Ellanya Kallabat, Corewell Health East Resident
• Roy Soto, Corewell Health East

Document Type

Conference Proceeding

Publication Date

10-18-2026

Abstract

We report the case of a 56-year-old woman undergoing a left parotidectomy with a past medical history of type 2 diabetes mellitus treated with a GLP‐1 agonist and a history notable for chronicoxycodone use for fibromyalgia‐related pain. This case highlights the convergent impact of GLP‐1 agonists and opioids, which are both known to delay gastric emptying, on anesthetic planning and aspiration risk. This case underscores the need for heightened vigilance and individualized anesthetic strategies as the prevalence of GLP‐1 agonist use continues to rise.

Comments

American Society of Anesthesiologists, The Anesthesiology Meeting, October 16-20, 2026, San Diego, 

Recommended Citation

Raza Z, Kallabat E, Soto R. Anesthetic management for concurrent glp-1 and opioid use. Presented at: American Society of Anesthesiologists, The Anesthesiology Meeting; 2026 Oct 18; San Diego, CA. Available from: https://www.abstractsonline.com/pp8/#!/21448/presentation/7467